Bedi [49] suggested that IL-18 may stimulate LL-37 expression by inducing IFN-γ, increasing cathelicidin concentration, and thus influencing LDL cholesterol metabolism and the development of atherosclerosis [47,50]. This evidence concerns the gene CAMP and atherosclerosis.